Methods of using Fc-cytokine fusion proteins
Disclosed herein are methods and compositions for enhancing the immunogenicity of a preselected protein or peptide antigen in a mammal. Immunogenicity is enhanced by fusing the preselected antigen to an immunoglobulin heavy chain constant region to produce an Fc-antigen fusion protein. The Fc-antigen fusion proteins bind Fc receptors on the surface of antigen presenting cells, thereby targeting the antigen to the antigen presenting cells in the mammal. In addition, disclosed is a family of adjuvants, for example, an Fc-adjuvant fusion protein, for use in combination with the Fc-antigen fusion proteins to enhance or modulate a particular immune response against the preselected antigen.
1. An anti-viral method comprising administering an Fc-cytokine fusion protein whose ability to bind an Fc receptor is not modified by mutation, wherein the Fc-cytokine fusion protein lacks an immunoglobulin variable domain and comprises an immunoglobulin heavy chain constant region having two polypeptide chains, either one of which is linked to a cytokine.
2. The anti-viral method of claim 1 , wherein the cytokine is directly linked to the polypeptide chain.
3. The anti-viral method of claim 1 , wherein the fusion protein is administered intravenously, subcutaneously, orally, buccally, intranasally, parenterally, rectally, vaginally or by aerosol administration.
4. The anti-viral method of claim 1 , wherein the cytokine is a human cytokine.
5. An anti-viral method comprising administering an Fc-cytokine fusion protein whose ability to bind an Fc receptor is not modified by mutation, wherein the Fc-cytokine fusion protein lacks an immunoglobulin variable domain and comprises an immunoglobulin heavy chain constant region having two polypeptide chains, either one of which is linked to a cytokine, wherein the cytokine is interleukin-2.
6. An anti-viral method comprising administering an Fc-cytokine fusion protein whose ability to bind an Fc receptor is not modified by mutation, wherein the Fc- cytokine fusion protein lacks an immunoglobulin variable domain and comprises an immunoglobulin heavy chain constant region having two polypeptide chains, either one of which is linked to a cytokine, wherein the cytokine is an interferon.